SCHEMBL4290450

SCHEMBL4290450

O=C(O)N1CCN[C@H](CCn2cc(CO)nn2)C1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
CA1 P00915 4/20 0.37
CA2 P00918 4/20 0.37
CA4 P22748 4/20 0.37
CA9 Q16790 4/20 0.37
ALDH1A1 P00352 1/20 0.35
HRH4 Q9H3N8 2/20 0.34
HRH3 Q9Y5N1 2/20 0.34
DPP4 P27487 1/20 0.34
NOTUM Q6P988 3/20 0.33
BCHE P06276 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PARP1 P09874 2/20 0.31
PIM1 P11309 1/20 0.31
PIM3 Q86V86 1/20 0.31
GPR88 Q9GZN0 1/20 0.30
REN P00797 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4291831 0.99 POLB (0.41) POLBKMT2ACA1CA2CA4
Hydrochloric Acid SCHEMBL4283908 0.90 KMT2A (0.53) POLBKMT2ACA1CA2CA4
Hydrochloric Acid SCHEMBL4291345 0.84 GPR88 (0.36) POLBKMT2ACA1CA2CA4
Hydrochloric Acid SCHEMBL4752027 0.82 CA1 (0.34) POLBKMT2ACA1CA2CA4
Hydrochloric Acid SCHEMBL4294021 0.82 CYP19A1 (0.34) POLBKMT2ACA1CA2CA4
Hydrochloric Acid SCHEMBL4282906 0.82 CA1 (0.34) POLBKMT2ACA1CA2CA4
SCHEMBL4297909 0.78 ALDH1A1 (0.47) POLBKMT2ACA1CA2CA4
SCHEMBL4283151 0.78 HRH4 (0.34) POLBKMT2AHRH4HRH3DPP4
Hydrochloric Acid SCHEMBL4288220 0.78 ALDH1A1 (0.46) POLBKMT2ACA1CA2CA4
SCHEMBL4285577 0.75 CA1 (0.35) KMT2ACA1CA2CA4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227560-A1 Substituted imidazole compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227560-A1 Substituted imidazole compound and use thereof REN, ACE, AGT POLB 3799/4885KMT2A 1049/4885CA1 2275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.